Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10753059rdf:typepubmed:Citationlld:pubmed
pubmed-article:10753059lifeskim:mentionsumls-concept:C0030391lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:10753059lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:10753059pubmed:issue2lld:pubmed
pubmed-article:10753059pubmed:dateCreated2000-5-2lld:pubmed
pubmed-article:10753059pubmed:abstractTextTwo monoclonal antibodies (mAbs) specific for the human parainfluenza virus type 2 (hPIV-2) V protein were obtained by immunizing mice with the V protein recombinantly expressed in Escherichia coli. Both mAbs were found to react with the V protein in ELISA and in Western blot analysis. Using these mAbs and previously obtained mAbs specific for hPIV-2 nucleoprotein (NP) or hPIV-2 phospho-(P) protein, we examined the intracellular distributions of the V, P and NP proteins in hPIV-2-infected cells by indirect immunofluorescence analyses. The P and NP proteins were organized in numerous granules in the cytoplasm of hPIV-2 infected cells. In contrast, the V protein showed diffuse nuclear and cytoplasm distributions.lld:pubmed
pubmed-article:10753059pubmed:languageenglld:pubmed
pubmed-article:10753059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:citationSubsetIMlld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10753059pubmed:statusMEDLINElld:pubmed
pubmed-article:10753059pubmed:monthNovlld:pubmed
pubmed-article:10753059pubmed:issn0300-8584lld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:ItoMMlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:ItoYYlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:KawanoMMlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:NishioMMlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:KomadaHHlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:TsurudomeMMlld:pubmed
pubmed-article:10753059pubmed:authorpubmed-author:KusagawaSSlld:pubmed
pubmed-article:10753059pubmed:issnTypePrintlld:pubmed
pubmed-article:10753059pubmed:volume188lld:pubmed
pubmed-article:10753059pubmed:ownerNLMlld:pubmed
pubmed-article:10753059pubmed:authorsCompleteYlld:pubmed
pubmed-article:10753059pubmed:pagination79-82lld:pubmed
pubmed-article:10753059pubmed:dateRevised2007-2-21lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:meshHeadingpubmed-meshheading:10753059...lld:pubmed
pubmed-article:10753059pubmed:year1999lld:pubmed
pubmed-article:10753059pubmed:articleTitleIsolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells.lld:pubmed
pubmed-article:10753059pubmed:affiliationDepartment of Microbiology, Mie University School of Medicine, Japan. nishio@doc.medic.mie-u.ac.jplld:pubmed
pubmed-article:10753059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10753059pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10753059pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10753059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10753059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10753059lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10753059lld:pubmed